nifedipine has been researched along with ramipril in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Sun, H | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ganten, D; Linz, W; Schölkens, BA | 1 |
| Balasia, BA; Berger, DS; Cholley, BP; Jain, S; Korcarz, C; Lang, RM; Marcus, RH; Murphy, MB; Sandelski, J; Shroff, SG | 1 |
| Amann, K; Mall, G; Nichols, C; Ritz, E; Schwarz, U; Tornig, J; Zeier, M | 1 |
| Amann, K; Mall, G; Nichols, C; Ritz, E; Törnig, J; Zeier, M | 1 |
| Chen, P; Dahl, D; Edwards, PA; Fenstermacher, JD; Guo, M; Scicli, AG; Scicli, GM | 1 |
| Albert, DH; Banfor, PN; Cox, BF; Davidsen, SK; Franklin, PH; Fryer, RM; Gintant, GA; Larson, KJ; Noonan, WT; Segreti, JA; Tapang, P; Widomski, DL | 1 |
| Farinde, A | 1 |
| De Angelis, MV; Di Stefano, V; Onofrj, M; Rispoli, MG | 1 |
1 review(s) available for nifedipine and ramipril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for nifedipine and ramipril
| Article | Year |
|---|---|
Differential effects of chronic oral antihypertensive therapies on systemic arterial circulation and ventricular energetics in African-American patients.
Topics: Administration, Oral; Analysis of Variance; Antihypertensive Agents; Atenolol; Black People; Cross-Over Studies; Double-Blind Method; Echocardiography; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nifedipine; Ramipril; Time Factors; Ultrasonography, Doppler; Ventricular Function, Left | 1995 |
12 other study(ies) available for nifedipine and ramipril
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Capture hydrolysis signals in the microsomal stability assay: molecular mechanisms of the alkyl ester drug and prodrug metabolism.
Topics: Carboxylic Acids; Cytochrome P-450 Enzyme System; Esters; Humans; Hydrolysis; Microsomes; Models, Molecular; Molecular Structure; Prodrugs; Quantum Theory; Signal Transduction | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bridged Bicyclo Compounds; Cardiomegaly; Dihydralazine; Hypertension; Male; Nifedipine; Ramipril; Rats; Rats, Inbred Strains | 1989 |
Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failure.
Topics: Animals; Antihypertensive Agents; Capillaries; Imidazoles; Kidney Failure, Chronic; Kidney Glomerulus; Male; Nephrectomy; Nifedipine; Ramipril; Rats; Rats, Sprague-Dawley; Renal Circulation | 1996 |
Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Thoracic; Arterioles; Calcium Channel Blockers; Capillaries; Coronary Disease; Coronary Vessels; Endomyocardial Fibrosis; Hemodynamics; Imidazoles; Kidney Failure, Chronic; Male; Nephrectomy; Nifedipine; Ramipril; Rats; Rats, Sprague-Dawley; Sympatholytics; Vasodilator Agents | 1996 |
Role of angiotensin II in retinal leukostasis in the diabetic rat.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Concanavalin A; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Intercellular Adhesion Molecule-1; Leukocyte Common Antigens; Leukostasis; Losartan; Male; Nifedipine; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Ramipril; Rats; Rats, Long-Evans; Retina; Retinal Diseases | 2006 |
Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor growt
Topics: Acrylates; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Enalapril; Humans; Imidazoles; Indazoles; Lisinopril; Male; Mice; Mice, SCID; Neoplasms; Nifedipine; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Ramipril; Rats; Rats, Sprague-Dawley; Telmisartan; Thiophenes; Xenograft Model Antitumor Assays | 2009 |
Drugs for treating hypertension.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drugs, Generic; Humans; Hydrochlorothiazide; Hypertension; Nifedipine; Prescription Drugs; Ramipril; Tetrazoles | 2013 |
Tumour-like presentation of atypical posterior reversible encephalopathy syndrome with prominent brainstem involvement.
Topics: Antihypertensive Agents; Brain Stem; Calcium Channel Blockers; Diagnosis, Differential; Doxazosin; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nifedipine; Posterior Leukoencephalopathy Syndrome; Ramipril; White Matter | 2020 |